D’Gama has reported a case (AN00090) harboring a germline missense mutations in SETD2 predicted to be deleterious (responsible for ASD) and a 15q deletion consistent with her diagnosis of Angelman syndrome (D'Gama et al., 2015). The gene discussed is SETD2; the disease is Angelman syndrome.